People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Naurex Inc. | — | Biotechnology | Series C | $156.0M | $3.3B | 2009 |
| BlinkBio, Inc. | — | Biotechnology | Series B | $43.6M | $20.8M | 2009 |
| Gate Neurosciences, Inc. | — | Pharmaceuticals | Series A | $16.1M | $247.9M | 2020 |
| Anagin, Inc. | — | Pharmaceuticals | Seed | $4.4M | $49.8M | 2016 |
Derek Small at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Derek Small on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Schulz | 2 | 3 |
| Mitchell S. Bloom | 1 | 7 |
| Terry Gould | 1 | 6 |
| Mark Simon | 1 | 6 |
| Geoff Smith | 1 | 6 |
| Colin Goddard | 1 | 5 |
| Douglas Reed | 1 | 4 |
| Norbert Riedel | 1 | 4 |
| Alan Lewis | 1 | 4 |
| Norbert G. Riedel | 1 | 3 |
| Robert J. Hombach | 1 | 3 |
| Nora Doherty | 1 | 3 |
| EDWARD K. CHANDLER | 1 | 3 |
| Terry P. Gould | 1 | 2 |
| Joseph R. Moskal | 1 | 2 |
| Ashish M. Khanna | 1 | 2 |
| Viren Mehta | 1 | 2 |
| Kapil Dhingra | 1 | 2 |
| Wilbur H. Gantz | 1 | 2 |
| Kenneth J. Widder | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.